## Abstract Many AIDS patients retain high CD4+ Tβcell counts despite a significant increase in PCR viral load after varied periods of treatment on drug combination with Highly Active Antiretroviral Therapy (HAART). In order to investigate this contradictory phenomenon, we assayed for infectious HI
β¦ LIBER β¦
Evaluation of Neuropsychological Performance of HIV-Infected Patients with Minor Motor Cognitive Dysfunction Treated with Highly Active Antiretroviral Therapy
β Scribed by A. S. Carvalhal; P. Belmonte-Abreu; J. Correa; L. Z. Goldani; S. B. Rourke
- Book ID
- 107705467
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 110 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Deletions in env gene of HIV-1 in AIDS p
β
Shreesh Saurya; Zelman Lichtenstein; Abraham Karpas
π
Article
π
2003
π
John Wiley and Sons
π
English
β 141 KB
Clearance of GB virus C during highly ac
β
H. Toyoda; T. Honda; Y. Katano; H. Goto; J. Takamatsu
π
Article
π
2005
π
Springer
π
English
β 51 KB
Reduced incidence of kaposi's sarcoma an
β
M.P. Carrieri; C. Pradier; P. Piselli; M. Piche; E. Rosenthal; P. Heudier; J. Du
π
Article
π
2002
π
John Wiley and Sons
π
French
β 50 KB
π 1 views
Outcome of HIV-Infected Patients With In
β
Ronney F. Stadler; Sharon G. Gregorcyk; David M. Euhus; Ronald J. Place; Philip
π
Article
π
2004
π
Springer
π
English
β 82 KB
Prospective Evaluation and Follow-Up of
β
J. L. Villanueva; A. AlarcΓ³n; M. Bernabeu-Wittel; E. Cordero; D. Prados; C. Rego
π
Article
π
2000
π
Springer
π
English
β 53 KB
Persistent parvovirus B19 related anemia
β
Mylonakis, Eleftherios; Dickinson, Brian P.; Mileno, Maria D.; Flanigan, Timothy
π
Article
π
1999
π
John Wiley and Sons
π
English
β 34 KB
π 2 views
A human immunodeficiency virus (HIV)-infected individual was first diagnosed with red blood cell aplasia due to B19 parvovirus infection in late 1989. Over the subsequent seven-year period, he received a total of 119 units of red blood cells (RBCs) and intravenous immunoglobulin every 2-3 weeks. In